Funding for Asian start-ups likely to slow amid coronavirus outbreak, if Sars and Zika any guide
- In 2003 and 2004, funding for Asian private companies declined by 27 per cent and 29 per cent respectively against 2002 levels
- The current coronavirus outbreak has not yet shown signs of slowing down, in terms of new infections
Financing for private companies in Asia is likely to slow amid the outbreak of the deadly coronavirus but could bounce back afterwards, according to a CB Insights report, which draws on how the 2003 Sars and 2016 Zika epidemics impacted markets in their respective regions.
It may add to an already cooling venture capital landscape in China amid the economic slowdown and the US-China trade war. In 2019, the amount of funding raised by Chinese startups fell 44 per cent from the year before to a total value of only US$54 billion, according to investment database CVSource.
In 2003 and 2004, funding for Asian private companies declined by 27 per cent and 29 per cent respectively against the level in 2002, according to CB Insights.
But both deal volume and funding started to recover in the third quarter of 2004, soon after the WHO announced China free of new cases in May that year.